Pacot, Maribeth .
HRN: 08-53-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
04/02/2025
04/09/2025
IV
750mg
Q24
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes